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Abstract: This study aimed to investigate the relationship between supervised exercise training
(SET)-induced changes in treadmill performance and 6 min walking distance, and changes in general
(physical and mental) self-perceived health-related quality of life (HRQoL) in symptomatic patients
with lower extremity peripheral artery disease (PAD). This is an observational study investigating
Fontaine stage II PAD patients participating in 3-month SET. Before and following SET, treadmill
performance (pain-free (PFWD) and maximal (MWD)), and 6 min walking distance (6MWD) were
assessed. Self-perceived HRQoL was assessed with the Medical Outcomes Study Short-Form 36
(SF-36). Ankle- and toe-brachial indexes were also measured. One-hundred forty-seven patients with
PAD were included (64.9 ± 9.6 y, 70% men). After SET, PFWD (+102%, p ≤ 0.001), MWD (+87%,
p ≤ 0.001), and 6MWD (+14%, p ≤ 0.001) significantly increased. All eight SF-36 subscale scores
significantly improved following SET (p ≤ 0.04). SET significantly improved physical and mental
component summaries of the SF-36 (p ≤ 0.001). Larger increases in 6MWD were associated with
greater improvements in physical (β = 0.19; p = 0.02) and mental (β = 0.24; p = 0.005) component
summaries of the SF-36. No significant relationship was observed between changes in treadmill
performance and changes in physical and mental component summaries of the SF-36. These results
show that improvements in 6MWD following SET are related to improvements in general self-
perceived HRQoL in patients with symptomatic lower extremity PAD. On the contrary, changes
in treadmill performance were not related to improvements in HRQoL. These results suggest that
the 6 min walking test is an essential outcome measure to assess overall patient functional status
following interventions in patients with PAD.
Keywords: vascular rehabilitation; walking performance; intermittent claudication; exercise therapy
1. Introduction
Lower extremity peripheral artery disease (PAD) is mostly secondary to atherosclerotic
arterial narrowing, resulting in reduced blood flow and oxygen delivery to the lower
limbs [1,2]. Patients with PAD have impaired walking performances and faster functional
decline compared to healthy age-matched subjects [3,4]. Consequently, these patients
reduce their daily life physical activity, adopting a more sedentary lifestyle behavior,
leading to further functional decline [5]. These functional limitations reduce health-related
quality of life (HRQoL), which reflects a patient’s physical, mental, and social perceptions
in relation to health [6].
Supervised exercise training (SET) is among the guideline-recommended therapies
for PAD [1,2]. It is well known that SET increases treadmill performance (pain-free (PFWD)
and maximal (MWD) walking distance) and 6 min walking distance (6MWD) compared
to usual care [7–11]. In addition, although often regarded as a secondary outcome, SET
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increases self-perceived HRQoL [7,11–13]. This latter result is promising as poor HRQoL
is associated with higher rates of mortality in patients with PAD [14]. However, the
relationship between a patient’s perceived improvements in general (physical and mental)
HRQoL and changes in treadmill performance and 6MWD following SET remains to be
clearly determined. This has clinical implications since treadmill performance and 6MWD
are commonly used outcome measures for assessing SET interventions in patients with
claudication. A recent study showed that greater 6MWD independently predicts better
physical and social aspects of quality of life in patients with PAD [15]. However, that study
had a cross-sectional design and did not assess treadmill performance [15]. In addition,
it has been demonstrated that changes in 6MWD following exercise therapy correlate
with changes in daily life physical activity and self-perceived walking distance in patients
with PAD [16]. Interestingly, no relationship was observed with changes in treadmill
performance [16]. A possible explanation is that, compared to the maximal treadmill test,
the 6 min walking is a submaximal test that is more representative of daily life walking.
As (walking) daily life activities are usually performed at submaximal levels, the 6 min
walking test may better represent overall patient functional status and better relate to a
patient’s perceptions in relation to health [16,17].
The present study aims to evaluate the relationship between SET-induced changes in
treadmill performance and 6 min walking distance, and changes in general (physical and
mental) self-perceived HRQoL in patients with symptomatic PAD. We hypothesized that
changes in 6MWD are related to changes in self-perceived HRQoL. On the contrary, we




Symptomatic patients with chronic PAD included in the Angiofit study at the Division
of Angiology of the University Hospital of Lausanne, Switzerland, were investigated. The
Angiofit study is a longitudinal observational cohort of symptomatic patients (Fontaine
stage II) participating in multimodal SET with stable uni- or bilateral lower limb claudi-
cation and resting ankle-brachial index (ABI) ≤ 0.9 or decreased post-exercise ABI > 20%.
We recently showed that our clinical multimodal SET is effective in improving walking
performance and quality of life [18–20] and that these improvements are maintained up to
12 months follow-up in patients with symptomatic PAD [20]. Compared to these previous
observations [18–20], in the present study we included all patients participating in our
clinical SET program up to 2020, having performed walking tests (treadmill and 6 min) and
self-perceived HRQoL questionnaire. Exclusion criteria are inability to participate in SET
three times weekly, critical limb ischemia, and cardiac contraindication to exercise. The
Angiofit study was approved by the local ethics committee and was conducted according
to the Declaration of Helsinki. Subjects provided written, voluntary, informed consent.
2.2. Multimodal Supervised Exercise Training Program
The clinical multimodal SET program was coordinated by an angiologist and directly
supervised by an exercise physiologist (SL), as recently described elsewhere [18–20]. SET
consisted of 36 sessions lasting 30–60 min, spread over a 3-month period (3x/week). Twice
weekly, patients performed outdoor Nordic walking, and once weekly indoor circuit
training focused on strengthening of lower limbs [18–20]. During Nordic walking sessions,
patients were encouraged to exercise until development of moderate-severe claudication
before resting [11]. Patients started again to exercise once pain disappeared. Exercise
intensity was mainly set at moderate intensity (12–14 on Borg’s scale) [21]. The indoor
circuit training included specific functional walking (toe/heel, high knees, side-to-side,
backward walking) or bodyweight resistance exercises (squat, calf/heel raise, lunges)
focused on the main lower limb muscles. At the beginning of SET, patients were asked to
perform 5–15 repetitions of each bodyweight resistance exercise interspersed with 30 to
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60 s of recovery and were encouraged to exercise at low intensity (9–11 on Borg’s scale).
Subsequently, if tolerated, patients were encouraged to exercise at moderate intensity
(12–14 on Borg’s scale). To that end, patients were encouraged to perform bodyweight
resistance exercises (e.g., 20–30 repetitions) or 10–20 repetitions using dumbbells or elastic
bands. Each training session started with a 5 min warm-up focused on coordination and
balance and ended with a 5 min cool-down period. During SET, patients participated in a
6 h structured therapeutic education workshop on PAD, tobacco, nutrition, and physical
activity. The attendance rate to SET was defined as the percentage of attended sessions out
of the total number of sessions.
2.3. Clinical and Functional Assessments
All assessments were routinely performed prior and following SET.
2.4. Patients’ Physical Characteristics
Physical examination, personal and medical history, and concomitant medications
were assessed. Body mass index (BMI), resting heart rate (HR), systolic (SBP) and diastolic
(DBP) blood pressure were recorded.
2.5. Vascular Parameters
ABI and toe-brachial indexes (TBI) were measured in supine position, as described
elsewhere [18–20]. Briefly, ABI was measured using a hand-held 5 MHz Doppler flow meter
(Atys Medical, Soucieu-en-Jarrest, France), and calculated as the ratio of ankle (dorsalis
pedis and posterior tibial) systolic blood pressure of each limb to the highest brachial SBP.
ABI post-exercise was also measured [1]. TBI was calculated using photoplethysmography
(Atys Medical, Soucieu-en-Jarrest, France) as the ratio of toe pressure to the highest brachial
SBP. The highest ABI and TBI values of the most symptomatic leg were considered.
2.6. Constant-Load Treadmill Test
To determine PFWD and MWD, patients performed a constant-load treadmill test
which was performed at 3.2 km/h with a 12% slope [11]. Speed was adapted depending
on patients’ safety and exercise tolerance ensuring that the same parameters were used
before and following SET.
2.7. Six-Minute Walking Test
Patients were asked to walk as far as possible within 6 min in an indoor 50 m corridor
to determine the 6MWD. Patients were allowed to stop during the test. While resting, they
were allowed to lean against the wall, but they were instructed to resume walking as soon
as they could, according to guidelines [22].
2.8. Health-Related Quality of Life
Medical Outcomes Study Short-Form 36 (SF-36) was used to evaluate self-perceived
HRQoL [23]. SF-36 is a validated generic self-administrated questionnaire assessing physi-
cal and mental components of health in eight subscales scored on a 0–100 scale (0 (worse
score) to 100 (best score)) [23]. Physical component (PCS) and mental component (MCS)
summaries were computed using weighting coefficients of a representative sample of peo-
ple living in Switzerland [24]. PCS is a weighted composite score of physical functioning,
physical role functioning, bodily pain, and general health subscales. MCS is a weighted
composite score of vitality, social role functioning, emotional role functioning, and mental
health [23,24].
2.9. Statistical Analysis
An intention-to-treat analysis approach was used. First, multiple imputations were
performed for patients who failed to complete the SET program [25,26]. T-tests and chi-
square tests were used to compare baseline characteristics of patients who completed vs.
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those that failed to complete the SET program. Multiple imputations for missing data were
performed to obtain twenty imputed data sets. We used a fully conditional specification
with predictive mean matching to impute all variables simultaneously [25,26]. Age, sex,
BMI, cardiovascular risks factors, comorbidities, ongoing treatment, vascular parameters,
and baseline outcome values were used to impute the data sets. Each individual item of the
SF-36 questionnaire was imputed, and summary scores were computed from the imputed
variables. Statistical (Kolmogorov–Smirnov test) and visual assessments of the normality
of distribution were performed. Comparisons between before and after SET program
were assessed using generalized linear model adjusted for covariates (age, sex), when
appropriate. In order to assess whether changes in treadmill performance (delta PFWD and
MWD) and 6 min walking distance (delta 6MWD) were related to changes in self-perceived
HRQoL (delta SF-36 scores) following SET, simple and multiple regression models were
computed. Covariates were added to the models when appropriate. Multicollinearity was
assessed to confirm that the independent variables were not highly correlated to each other.
This assumption was tested using variance inflation factor values. Statistical analyses
were performed with SPSS 27 software (IBM Corporation, Armonk, NY, USA). Level of
significance was set at p ≤ 0.05.
3. Results
3.1. Study Population
One hundred forty-seven symptomatic patients with chronic PAD were included
(Table 1). Of these, one hundred twenty-nine (88%) completed the SET program. Reasons
for not completing SET include dropping out for endovascular revascularization due
to worsening of claudication symptoms during SET (n = 4), and other reasons (such as
health reasons not related to SET, and work commitments, n = 14). Baseline characteristics
(age, sex, cardiovascular risks factors, vascular parameters, and baseline outcome values)
of patients who completed SET were similar to those who failed to complete SET. The
attendance rate to SET was 87 ± 2%.
Table 1. Baseline characteristics of the study population.
Characteristics Mean ± SD or n (%)
Number of included patients 147
Age—y 64.9 ± 9.6
BMI—kg·m−2 27.6 ± 5.1
Women 44 (30)
Cardiovascular risks factors
Type 2 diabetes mellitus 51 (35)
Hypertension 105 (71)
Smoking (current) 74 (50)
Smoking (former) 58 (40)
Smoking (never) 15 (10)
Hypercholesterolemia 117 (80)
Family history of CVD 37 (25)









Prior arterial revascularization 81 (55)
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Table 1. Cont.




Lipid lowering 108 (73)
Anticoagulant 15 (10)
Antidiabetic 50 (34)
BMI = body mass index; CVD = cardiovascular disease.
3.2. Treadmill Performance and 6 Min Walking Distance
PFWD (+102%), MWD (+87%), and 6MWD (+14%) significantly increased after
SET (Table 2).
Table 2. Treadmill performance and 6 min walking distance before and after supervised exercise training.
Variable Before After %Change Wald Chi-2 p Value
PFWD—m a 105.6 ± 110.8 213.4 ± 231.0 102 21.4 ≤0.001
MWD—m 324.1 ± 265.8 606.3 ± 456.5 87 63.3 ≤0.001
6MWD—m a 414.9 ± 87.5 471.8 ± 86.4 14 55.6 ≤0.001
Values are means ± SD. PFWD = pain-free walking distance; MWD = maximal walking distance; 6MWD =
six-minute walking distance. a adjusted for sex. The influence of covariates (age and sex) on the different outcomes
was assessed a priori with simple linear regression. Changes in PFWD (β = 0.17; p = 0.04) and 6MWD (β = 0.20;
p = 0.04) after training were significantly higher in women. In contrast, changes in MWD after training were
not related to sex (β = 0.14; p = 0.11). Therefore, generalized linear models were adjusted for sex for PFWD and
6MWD. Changes in PFWD, MWD, and 6MWD were not related to age.
3.3. Self-Perceived Health-Related Quality of Life
The eight subscale scores of the SF-36 significantly increased (best scores) after SET
(Table 3). Similarly, physical and mental component summaries of the SF-36 significantly
improved after SET (Table 3).
Table 3. Short-Form 36 scores before and after the supervised exercise training program.
Variable Before After Wald Chi-2 p Value
Physical Functioning 53.6 ± 18.4 61.2 ± 18.9 26.7 ≤0.001
Physical Role Functioning a 47.6 ± 39.5 65.4 ± 35.1 22.6 ≤0.001
Bodily Pain 47.5 ± 19.0 56.2 ± 17.3 30.0 ≤0.001
General Health 51.5 ± 16.2 53.9 ± 14.1 4.5 0.04
Physical Component Summary a 31.2 ± 9.7 35.9 ± 9.3 28.8 ≤0.001
Vitality 46.5 ± 16.7 52.6 ± 14.8 24.8 ≤0.001
Social Role Functioning 61.0 ± 24.2 68.4 ± 21.2 15.4 ≤0.001
Emotional Role Functioning 54.9 ± 39.7 71.3 ± 33.2 21.0 ≤0.001
Mental Health 64.2 ± 17.1 66.9 ± 15.8 5.6 0.02
Mental Component Summary 41.9 ± 11.6 45.7 ± 10.6 18.2 ≤0.001
Values are means ± SD. a adjusted for sex. The influence of covariates (age and sex) on the different outcomes was
assessed a priori with simple linear regression. Changes in physical role functioning score (β = 0.21; p = 0.01) and
physical component score (β = 0.21; p = 0.01) after training were significantly higher in women. In contrast, changes
in other scores after training were not related to sex. Therefore, generalized linear models were adjusted for sex for
physical role functioning score and physical component score. Changes in all scores were not related to age.
3.4. Changes in Treadmill Performance and 6 Min Walking Distance and Their Relationship to
Changes in Self-Perceived Health-Related Quality of Life Following SET
Larger increases in 6MWD were associated with greater improvements in physical
functioning, bodily pain, general health, vitality, and emotional role functioning subscale
scores of the SF-36 (Table 4). No significant relationship was observed between changes in
6MWD and changes in physical role functioning, social role functioning, and mental health
subscale scores of the SF-36 (Table 4). Larger increases in 6MWD were associated with
greater improvements in physical and mental component summaries of the SF-36 (Table 4).
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No significant relationship was observed between changes in treadmill performance and
changes in SF-36 subscales and summary components (Table 4). These results did not sub-
stantially change when analyses were performed without multiple imputations (Table 5).
Table 4. Changes in treadmill performance and 6 min walking distance and their relationship to changes
in health-related quality of life following supervised exercise training with multiple imputations.
Changes in Quality of Life
SF-36 Scores Delta PFWD Delta MWD Delta 6MWD
Physical Functioning β = −0.03; p = 0.74 β = 0.002; p = 0.98 β = 0.25; p = 0.003
Physical Role Functioning a β = −0.05; p = 0.61 β = 0.06; p = 0.53 β = 0.12; p = 0.15
Bodily Pain β = 0.02; p = 0.86 β = −0.03; p = 0.78 β = 0.21; p = 0.01
General Health β = −0.10; p = 0.30 β = −0.17; p = 0.07 β = 0.21; p = 0.01
Physical Component Summary a β = −0.05; p = 0.57 β = −0.01; p = 0.92 β = 0.19; p = 0.02
Vitality β = −0.18; p = 0.06 β = 0.12; p = 0.22 β = 0.26; p = 0.002
Social Role Functioning β = −0.09; p = 0.39 β = −0.01; p = 0.95 β = 0.16; p = 0.06
Emotional Role Functioning β = 0.02; p = 0.81 β = −0.07; p = 0.45 β = 0.26; p = 0.002
Mental Health β = −0.06; p = 0.51 β = 0.14; p = 0.14 β = 0.13; p = 0.14
Mental Component Summary β = −0.06; p = 0.51 β = 0.02; p = 0.87 β = 0.24; p = 0.005
PFWD = pain-free walking distance; MWD = maximal walking distance; 6MWD = six-minute walking distance.
β: standardized coefficient. a adjusted for sex.
Table 5. Changes in treadmill performance and 6 min walking distance and their relationship to changes
in health-related quality of life following supervised exercise training without multiple imputations.
Changes in Quality of Life
SF-36 Scores Delta PFWD Delta MWD Delta 6MWD
Physical Functioning β = −0.07; p = 0.50 β = −0.04; p = 0.69 β = 0.28; p = 0.006
Physical Role Functioning a β = −0.06; p = 0.55 β = 0.08; p = 0.45 β = 0.10; p = 0.31
Bodily Pain β = −0.03; p = 0.78 β = −0.03; p = 0.76 β = 0.26; p = 0.009
General Health β = −0.03; p = 0.78 β = −0.14; p = 0.18 β = 0.03; p = 0.78
Physical Component Summary a β = −0.07; p = 0.51 β = −0.03; p = 0.81 β = 0.15; p = 0.14
Vitality β = −0.19; p = 0.08 β = 0.20; p = 0.06 β = 0.09; p = 0.36
Social Role Functioning b β = −0.08; p = 0.46 β = −0.06; p = 0.96 β = 0.13; p = 0.19
Emotional Role Functioning β = −0.01; p = 0.89 β = −0.06; p = 0.55 β = 0.31; p = 0.002
Mental Health β = −0.12; p = 0.24 β = 0.16; p = 0.13 β = 0.22; p = 0.03
Mental Component Summary β = −0.09; p = 0.38 β = 0.02; p = 0.86 β = 0.27; p = 0.008
PFWD = pain-free walking distance; MWD = maximal walking distance; 6MWD = six-minute walking distance.
β: standardized coefficient. a adjusted for sex; b adjusted for age.
3.5. Vascular Parameters and Physical Characteristics
ABI at rest and after treadmill test remained unchanged after SET (Table 6). TBI
significantly increased after SET (mean difference: 0.03) (Table 6). Resting HR, SBP, DBP,
body mass, and BMI, were unchanged after SET (Table 6).
Table 6. Vascular parameters and physical characteristics before and after supervised exercise training.
Variable Before After Wald Chi-2 p Value
ABI 0.82 ± 0.22 0.81 ± 0.19 0.1 0.73
ABIpEx (% decrement) 43.9 ± 22.6 42.3 ± 21.8 0.8 0.38
TBI 0.60 ± 0.18 0.63 ± 0.16 4.5 0.03
Resting HR—bpm 71 ± 12 69 ± 10 3.5 0.07
SBP—mmHg 145 ± 18 146 ± 18 0.8 0.37
DBP—mmHg 79 ± 11 78 ± 10 0.2 0.67
Body mass—kg 78.1 ± 16.3 78.7 ± 15.8 1.2 0.27
BMI—kg·m−2 27.6 ± 5.1 27.9 ± 5.1 1.4 0.24
Values are means ± SD. ABI = ankle-brachial index; ABIpEx = post-exercise ABI; TBI = toe-brachial index; SBP =
systolic blood pressure; DBP = diastolic blood pressure; BMI = body mass index. The influence of covariates (age
and sex) on the different outcomes was assessed a priori with simple linear regression. Changes in all variables
were not related to sex and/or age.
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4. Discussion
Results presented herein confirm our hypothesis and show that larger increases in
6MWD were associated with greater improvements in physical and mental self-perceived
HRQoL in patients with symptomatic PAD. On the contrary, changes in treadmill perfor-
mance were not related to improvements in HRQoL.
The association between patients’ perceived improvements in quality of life and
changes in treadmill (PFWD and MWD) and functional (6MWD) walking performance
following exercise therapy is understudied in patients with symptomatic PAD. From a
clinical standpoint, this has a great importance since treadmill performance and 6MWD
are commonly used outcome measures for assessing SET interventions in patients with
claudication. The novelty of the present investigation is that larger increases in 6MWD
following SET were associated with greater improvements in physical and mental self-
perceived HRQoL. On the contrary, changes in treadmill performance were not related to
improvements in HRQoL. These results suggest the importance of changes in functional
walking on improvements in HRQoL. These results are in line with recent findings showing
that changes in 6MWD following 6-month exercise therapy correlate with changes in daily
life physical activity and self-perceived walking distance in patients with PAD [16]. It is
interesting to note that the significant correlation between changes in 6MWD and daily
life physical activity was reported following different types of exercise interventions [16].
Indeed, this correlation was reported following a home-based overground walking training
in the GOALS trial and following supervised treadmill training in the SILC trial as well [16].
In contrast, no relationship was observed with changes in treadmill performance [16]. We
speculate that the results of the present investigation are linked to the more functional
characteristics of the 6 min walking test. Although the treadmill test is widely performed
to determine maximal exercise capacity, this test is not representative of daily life walking
conditions [16,17]. Indeed, patients have to maintain a specific walking speed on an inclined
(incremental or constant [11]) treadmill slope and usually hold the treadmill handrail to
maintain balance [17]. On the other hand, the 6 min walking is a submaximal test that is
performed on a flat corridor where patients can choose the walking speed and are allowed
to stop and rest. As (walking) daily life activities are usually performed at submaximal
levels, the 6 min walking test may better represent functional exertion in these conditions.
Taken together, our results suggest that the 6 min walking test is an essential outcome
measure to assess overall patient functional status following interventions [16,17]. Our
results are also in line with recent findings showing that SF-36 scores are mainly predicted
by physical functional markers such as 6MWD, history of stumbling, and daily walking
cadence in patients with PAD [27]. In addition, Golledge et al. [15] recently showed that
6MWD independently predicts physical and social aspects of quality of life in patients with
PAD. These results suggest that interventions aiming at improving functional (walking)
daily life activities are expected to have greater improvements in self-perceived HRQoL [27].
Further studies are needed to better assess this speculation in the future.
Self-perceived HRQoL following exercise therapy have not been widely investigated
in patients with PAD, and the findings are inconsistent [7,12,13]. Indeed, it has been previ-
ously shown that 3- [28–30], or 6/12-month [31–33] exercise therapy improves a patient’s
perception of physical HRQoL, with less (or no) effect on mental HRQoL. On the contrary,
other studies showed no change in self-perceived physical and mental HRQoL following
exercise therapies of similar durations [34–36]. Reasons for discrepancies among studies
may be related to differences in study population (age, comorbidities, medical history, base-
line overall physical function), and/or in exercise training modalities. Results presented
herein showed that 3-month multimodal SET improves patients’ overall perceptions of
physical and mental HRQoL. Although the design of the present study cannot discriminate
whether multimodal SET is superior to treadmill and/or other training modalities, we
speculate that improvements in overall self-perceived HRQoL may be related to func-
tional characteristics of our multimodal SET. More research is needed to investigate the
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effects of different training modalities in improving self-perceived HRQoL in patients with
symptomatic PAD.
Some methodological limitations need to be addressed. First, exercise training was
3 months in duration. If these results are also applicable to traditional longer (6 months) or
shorter training durations remains to be determined. Second, missing data had to be re-
placed using multiple imputations. However, this procedure allowed increasing statistical
power and avoided possible selection bias. In addition, the results did not substantially
change when analyses were performed without multiple imputations, highlighting the
robustness of our imputation method. Third, the treadmill protocol used to evaluate
walking capacities may have influenced the treadmill outcomes. It has been demonstrated
that the type of intervention (home-based overground walking vs. treadmill training)
may result in difference in outcome in patients with PAD [16]. Indeed, treadmill training
results in improved treadmill performance but not (or to a lesser extent) in 6MWD, whereas
overground walking (common in home-based programs) elicits greater improvements in
6MWD and fewer changes in treadmill performance [16]. It is, however, interesting to
note that in the present investigation, where patients performed an overground functional
exercise therapy program, treadmill performance improved more than the 6MWD. This
may be related to the treadmill protocol. Indeed, constant-load treadmill protocols have
lower test–retest reliability and have a more pronounced learning/placebo effect than
graded protocols [37]. However, in the present study we used a constant-load protocol
with a 12% slope, which is the grade with the greatest test–retest reliability when using
constant-load protocols [38]. Fourth, we used a generic questionnaire of quality of life
(SF-36) and it would be interesting in the future to also assess associations of treadmill and
functional walking performance with disease-specific quality of life questionnaires, such as
the Walking Impairment Questionnaire (WIQ), the Peripheral Arterial Occlusive Disease
86 (PAVK-86) questionnaire, the Intermittent Claudication questionnaire, or the VascuQoL
questionnaire.
In conclusion, the results presented herein showed that improvements in 6MWD
following SET are related to improvements in general self-perceived HRQoL in patients
with symptomatic PAD. On the contrary, changes in treadmill performance were not related
to improvements in HRQoL. These results suggest that the 6 min walking test is an essential
outcome measure to assess overall patient functional status following interventions.
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